Brachytherapy for Prostate Cancer

Prostate cancer treatments – brachytherapy

The condition is age related, more often appearing in people over seventy years old, and it is very rare in people under the age of forty. As a consequence of new technology and more widespread testing the average age of sufferers is coming down; this has enabled treatments such as Brachytherapy to become much more effective; see the brachytherapy procedures and brachytherapy side effects sections for more information.
It is the aim of the prostate cancer guide to educate people about the condition.

In doing so it hoped that the reader will be able to feel more positive about themselves, and the minds of loved ones will be eased. It is intended that the site acts as a valuable source of information on the causes, symptoms and treatments, such as brachytherapy of prostate cancers.

Side effects of brachytherapy for prostate cancer

The percentage of people who become impotent following brachytherapy is in the range of six to fifty percent. As the brachytherapy treatment leaves nerves intact the use of drugs can be very useful in overcoming any sexual difficulties. Following the brachytherapy seed implants it is recommended to wait at least two weeks before performing any sexual activity. Unfortunately following brachytherapy for prostate cancer a man is likely to be unfertile.

Prostate Brachytherapy Urinary side effects

Other side effects of treatments for prostate cancer:
Most of the side effects associated with brachytherapy are urinary in nature, following the treatment the patient may feel the need to urinate much more frequently than normal for a period of about three months. Whilst other patients may not be able to urinate at all, this is chiefly as a consequence of the prostate swelling following the implant. In the worst cases a patient may require a catheter; however this is usually only required for about seven days. The brachytherapy treatment does not usually result in a complete urinary incontinence, and the overall risk is quite negligible, much less than 1 percent. This is mainly because advances in radiotherapy have led to more accurate procedures and the muscles that control the urinary function does not receive a radioactive dose.